KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Idexx Laboratories (IDXX) over the last 17 years, with Q3 2025 value amounting to $1.8 billion.

  • Idexx Laboratories' Total Liabilities rose 535.66% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 535.66%. This contributed to the annual value of $1.7 billion for FY2024, which is 435.2% down from last year.
  • Per Idexx Laboratories' latest filing, its Total Liabilities stood at $1.8 billion for Q3 2025, which was up 535.66% from $1.9 billion recorded in Q2 2025.
  • Over the past 5 years, Idexx Laboratories' Total Liabilities peaked at $2.2 billion during Q3 2022, and registered a low of $1.6 billion during Q1 2021.
  • In the last 5 years, Idexx Laboratories' Total Liabilities had a median value of $1.8 billion in 2024 and averaged $1.8 billion.
  • In the last 5 years, Idexx Laboratories' Total Liabilities skyrocketed by 3274.18% in 2022 and then plummeted by 1735.82% in 2023.
  • Quarter analysis of 5 years shows Idexx Laboratories' Total Liabilities stood at $1.7 billion in 2021, then increased by 22.37% to $2.1 billion in 2022, then decreased by 16.96% to $1.8 billion in 2023, then dropped by 4.35% to $1.7 billion in 2024, then grew by 7.5% to $1.8 billion in 2025.
  • Its Total Liabilities stands at $1.8 billion for Q3 2025, versus $1.9 billion for Q2 2025 and $1.8 billion for Q1 2025.